Volume 43, no. 8, p. 1817–1826. 1999. Page 1819: Table 2
Table.
| Drug | pKa | CPR/CP | CSV/CP | Cother/CP | CS/CP |
|---|---|---|---|---|---|
| Weak acids | |||||
| Didanosine | 9.1 | 1.0 | 1.0 | 1.0 | 1.0 |
| Zidovudine | 9.7 | 1.0 | 1.0 | 1.0 | 1.0 |
| Efavirenz | 10.2 | 1.0 | 1.0 | 1.0 | 1.0 |
| Nelfinavir | 11.1 | 1.0 | 1.0 | 1.0 | 1.0 |
| Weak bases | |||||
| Abacavir | 5.1 | 1.0 | 1.0 | 1.0 | 1.0 |
| Lamivudine | 4.3 | 1.0 | 1.0 | 1.0 | 1.0 |
| Zalcitabine | 4.4 | 1.0 | 1.0 | 1.0 | 1.0 |
| Indinavir | 6.2 | 1.4 | 1.0 | 1.0 | 1.1 |
| Ritonavir | 2.8 | 1.0 | 1.0 | 1.0 | 1.0 |
| Saquinavir | 1.1/7.1 | 1.0–3.3 | ∼1.0 | ∼1.0 | ∼1.5 |
| Delavirdine | 4.6 | 1.0 | 1.0 | 1.0 | 1.0 |
| Nevirapine | 2.8 | 1.0 | 1.0 | 1.0 | 1.0 |
should appear as shown below.